tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Acumen Pharmaceuticals’ Earnings Call: Progress and Challenges
PremiumCompany AnnouncementsAcumen Pharmaceuticals’ Earnings Call: Progress and Challenges
1M ago
Acumen Pharmaceuticals Reports Q3 Financial Results
Premium
Company Announcements
Acumen Pharmaceuticals Reports Q3 Financial Results
1M ago
Acumen reports Q3 EPS (44c), consensus (68c)
Premium
The Fly
Acumen reports Q3 EPS (44c), consensus (68c)
1M ago
Acumen price target lowered to $4 from $11 at BTIG
PremiumThe FlyAcumen price target lowered to $4 from $11 at BTIG
2M ago
Acumen Pharmaceuticals’ Earnings Call Highlights Strategic Growth
Premium
Company Announcements
Acumen Pharmaceuticals’ Earnings Call Highlights Strategic Growth
4M ago
Acumen price target lowered to $9 from $10 at BofA
Premium
The Fly
Acumen price target lowered to $9 from $10 at BofA
4M ago
ABOS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsABOS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
Acumen Pharmaceuticals’ Promising Alzheimer’s Study: A Potential Game-Changer?
Premium
Company Announcements
Acumen Pharmaceuticals’ Promising Alzheimer’s Study: A Potential Game-Changer?
5M ago
Acumen presents results from its Phase 2 ALTITUDE-AD study of sabirnetug
Premium
The Fly
Acumen presents results from its Phase 2 ALTITUDE-AD study of sabirnetug
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100